The solvated title compound, C 13 H 8 ClN 3 O 2 ÁCHCl 3 , is a product of a condensation reaction between 2-amino-N-(2-chloropyridin-3-yl)benzamide and phosgene. The presence of the chlorine substituent in the pyridine ring forces the latter to adopt a nearly perpendicular orientation relative to the planar quinazoline ring (r.m.s. deviation = 0.04 Å ), the two ring systems being inclined to one another by 84.28 (9) . In the crystal, molecules are linked by pairs of N-HÁ Á ÁO hydrogen bonds, forming inversion dimers with an R 2 2 (8) ring motif. The dimers are linked by C-HÁ Á ÁO hydrogen bonds, forming ribbons propagating along the a-axis direction. The chloroform solvent molecules are linked to the organic molecule by C-HÁ Á ÁN hydrogen bonds.
The solvated title compound, C 13 H 8 ClN 3 O 2 ÁCHCl 3 , is a product of a condensation reaction between 2-amino-N-(2-chloropyridin-3-yl)benzamide and phosgene. The presence of the chlorine substituent in the pyridine ring forces the latter to adopt a nearly perpendicular orientation relative to the planar quinazoline ring (r.m.s. deviation = 0.04 Å ), the two ring systems being inclined to one another by 84.28 (9) . In the crystal, molecules are linked by pairs of N-HÁ Á ÁO hydrogen bonds, forming inversion dimers with an R 2 2 (8) ring motif. The dimers are linked by C-HÁ Á ÁO hydrogen bonds, forming ribbons propagating along the a-axis direction. The chloroform solvent molecules are linked to the organic molecule by C-HÁ Á ÁN hydrogen bonds.
Structure description
The title compound results from our ongoing research aimed at the development of subtype-selective ligands for muscarinic receptors (Tahtaoui et al., 2004; Mohr et al., 2010) . It was isolated as a side-product in the course of the synthesis of AFDX-type allosteric modulators of muscarinic M2 receptors (Mohr et al., 2004) . Specifically, the incomplete condensation between ethyl 2-aminobenzoate and 3-amino-2-chloropyridine (Holzgrabe & Heller, 2003) gave the ring-opened 2-amino-N-(2-chloropyridin-3-yl)-benzamide (1) in 23% yield. This compound, (1), was subjected to condensation with phosgene giving the title compound (2) in 85% yield. This two-step approach is of general interest for the synthesis of differently substituted (1H,3H)-quinazoline-2,4-diones.
The molecular structure of the title compound (2), which crystallized as a chloroform monosolvate, is shown in Fig. 1 . The pyridine ring (N1/C1-C5) is nearly perpendicular to the planar quinazoline ring (N2/N3/C6-C13; r.m.s. deviation = 0.04 Å ), making a dihedral angle of 84.28 (9) .
data reports
In the crystal, molecules are linked by pairs of N-HÁ Á ÁO hydrogen bonds forming inversion dimers, with an R 2 2 (8) ring motif ( Fig. 2 and Table 1 ). The chloroform solvate molecules are linked to the organic molecule by C-HÁ Á ÁN hydrogen bonds, and the dimers are linked by C-HÁ Á ÁO hydrogen bonds, forming ribbons propagating along the a-axis direction ( Fig. 2 and Table 1 ).
Synthesis and crystallization
2-Amino-N-(2-chloropyridin-3-yl)benzamide (1).
3-Amino-2-chloropyridine (2.57 g, 20.0 mmol), ethyl 2-aminobenzoate (3.39 g, 20.5 mmol) and KO t Bu (7.29 g, 65.0 mmol) were suspended in dry 1,4-dioxane (100 ml) under argon. The mixture was heated by microwaves (gradient of heating: 2 min to 333 K; holding time: 10 min at 333 K; gradient of heating: 3 min from 333-373 K; holding time: 2.5 h at 373 K). After cooling to 298 K, the solution was treated with 1 M NaH 2 PO 4 (60 ml) and stirred for 30 min. The dioxane was evaporated in vacuo and the residue was treated with 50 ml water. The solid obtained was filtered and dried. The product (1) 1616, 1578, 1569, 1503, 1486, 1391, 802, 743, 735 . MS (ESI): m/z (%): 248.2 (M+1).
3-(2-Chloropyridin-3-yl)quinazoline-2,4-(1H,3H)dione (2). Compound (1) (4.22 g, 20.0 mmol) and Hueunig's base (7.0 ml, 40.0 mmol) were dissolved in dry 1,4-dioxane (150 ml) under argon. A solution of 20% phosgene in toluene (18.5 ml, 35.0 mmol) was added dropwise over 30 min. The solution was heated using microwaves (gradient of heating: 3 min to 358 K; holding time: 2 h at 358 K). After cooling to 298 K, the A view along the c axis of the crystal packing of the solvated title compound, (2)ÁCHCl 3 . The hydrogen bonds are shown as dashed lines (see Table 1 ). For clarity, only the H atoms involved in hydrogen bonding have been included. Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz þ 1; (ii) x; y À 1; z; (iii) x þ 1; y; z. Computer programs: APEX2 and SAINT (Bruker, 2013) , olex2.solve (Bourhis et al., 2015) , SHELXL2014 (Sheldrick, 2015) , Mercury (Macrae et al., 2008) , OLEX2 (Dolomanov et al., 2009) , SHELXL2014 (Sheldrick, 2015) , enCIFer (Allen et al., 2004) and publCIF (Westrip (2010) .
Figure 1
The molecular structure of the solvated title compound, (2)ÁCHCl 3 , with the atom labelling and displacement ellipsoids drawn at the 50% probability level.
mixture was quenched with 1.0 M NaH 2 PO 4 (100 ml) and stirred for 1 h at room temperature. 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 .
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data-2

